Neuroonkologie
Molekulare Diagnostik und Therapie III

Programm

• 08:30 – 08:40 7 Min. 3 Min.

  • Abstractvortrag

  Integration of high-throughput in vitro drug screening and molecular profiling to characterize novel, molecularly targeted treatment approaches for glioblastoma

  • Johanna Louise Trübel (Düsseldorf)
• 08:40 – 08:50 7 Min. 3 Min.

  • Abstractvortrag

  Frailty and temporal muscle mass as predictors of immunotherapy response and overall survival in patients with brain metastases of non-small cell lung cancer

  • Harald Krenzlin (Mainz)
• 08:50 – 09:00 7 Min. 3 Min.

  • Abstractvortrag

  Tumor edema of menigeomas and the relationship to a DNA methylation-based grading system and the integrated model score

  • Silvio Ginsberg (Gießen)
• 09:00 – 09:10 7 Min. 3 Min.

  • Abstractvortrag

  Protoporphyrin IX (PpIX) fluorescence during meningioma surgery: Correlations with histological findings and expression of key heme biosynthesis pathway molecules

  • Dorothee Spille (Münster)
• 09:10 – 09:20 7 Min. 3 Min.

  • Abstractvortrag

  Prognostic impact of obesity in newly-diagnosed glioblastoma: A secondary analysis of CeTeG/NOA-09 and GLARIUS

  • Matthias Schneider (Bonn)